(ARMK) Aramark Holdings - Ratings and Ratios
Food Services, Facilities Services, Catering, Vending, Custodial
EPS (Earnings per Share)
Revenue
| Risk via 10d forecast | |
|---|---|
| Volatility | 27.0% |
| Value at Risk 5%th | 41.6% |
| Relative Tail Risk | -6.35% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.06 |
| Alpha | -10.36 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.425 |
| Beta | 0.864 |
| Beta Downside | 0.841 |
| Drawdowns 3y | |
|---|---|
| Max DD | 27.63% |
| Mean DD | 9.49% |
| Median DD | 9.42% |
Description: ARMK Aramark Holdings October 30, 2025
Aramark Holdings (NYSE: ARMK) delivers food and facilities services across education, healthcare, business & industry, sports & leisure, and corrections markets in the United States and abroad, organized into two reporting segments: Food & Support Services U.S. and Food & Support Services International.
The company’s portfolio includes managed dining, catering, and retail food operations; non-clinical patient nutrition and environmental services; and a suite of facility-management offerings such as custodial, energy management, grounds keeping, and capital-project oversight. It also runs on-site restaurants, vending, concessions, and hospitality services for sports and entertainment venues, plus correctional food, commissaries, and laundry facilities.
Key recent metrics: FY 2023 revenue of $15.4 billion, adjusted EBITDA margin of roughly 7 %, and a contract backlog of about $3.5 billion, indicating a solid pipeline. The business is sensitive to macro drivers such as institutional food-service demand, labor-cost inflation, and commodity price volatility, while the shift toward outsourced non-core services in hospitals and universities supports top-line growth.
For a deeper, data-driven assessment of ARMK’s valuation and risk profile, the ValueRay platform provides a comprehensive dashboard for further research.
ARMK Stock Overview
| Market Cap in USD | 9,720m |
| Sub-Industry | Restaurants |
| IPO / Inception | 2013-12-12 |
| Return 12m vs S&P 500 | -18.2% |
| Analyst Rating | 4.43 of 5 |
ARMK Dividends
| Metric | Value |
|---|---|
| Dividend Yield | 1.11% |
| Yield on Cost 5y | 1.72% |
| Yield CAGR 5y | -2.97% |
| Payout Consistency | 97.0% |
| Payout Ratio | 23.9% |
ARMK Growth Ratios
| Metric | Value |
|---|---|
| CAGR 3y | 10.03% |
| CAGR/Max DD Calmar Ratio | 0.36 |
| CAGR/Mean DD Pain Ratio | 1.06 |
| Current Volume | 2265k |
| Average Volume | 2279.5k |
Piotroski VR‑10 (Strict, 0-10) 3.5
| Net Income (326.4m TTM) > 0 and > 6% of Revenue (6% = 1.11b TTM) |
| FCFTA 0.03 (>2.0%) and ΔFCFTA 1.06pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue -0.13% (prev -4.64%; Δ 4.51pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.07 (>3.0%) and CFO 921.0m > Net Income 326.4m (YES >=105%, WARN >=100%) |
| Net Debt (5.08b) to EBITDA (1.25b) ratio: 4.07 <= 3.0 (WARN <= 3.5) |
| Current Ratio 0.99 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (267.0m) change vs 12m ago -0.36% (target <= -2.0% for YES) |
| Gross Margin 7.69% (prev 8.19%; Δ -0.51pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 142.5% (prev 137.3%; Δ 5.18pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 2.26 (EBITDA TTM 1.25b / Interest Expense TTM 341.9m) >= 6 (WARN >= 3) |
Altman Z'' 0.81
| (A) -0.00 = (Total Current Assets 3.52b - Total Current Liabilities 3.55b) / Total Assets 13.30b |
| (B) 0.03 = Retained Earnings (Balance) 393.7m / Total Assets 13.30b |
| (C) 0.06 = EBIT TTM 772.4m / Avg Total Assets 12.99b |
| (D) 0.31 = Book Value of Equity 3.15b / Total Liabilities 10.14b |
| Total Rating: 0.81 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 57.15
| 1. Piotroski 3.50pt |
| 2. FCF Yield 3.07% |
| 3. FCF Margin 2.46% |
| 4. Debt/Equity 1.82 |
| 5. Debt/Ebitda 4.07 |
| 6. ROIC - WACC (= 0.42)% |
| 7. RoE 10.59% |
| 8. Rev. Trend 68.42% |
| 9. EPS Trend 28.49% |
What is the price of ARMK shares?
Over the past week, the price has changed by +4.97%, over one month by -5.16%, over three months by -4.16% and over the past year by -8.66%.
Is ARMK a buy, sell or hold?
- Strong Buy: 8
- Buy: 4
- Hold: 2
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the ARMK price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 44.6 | 17.9% |
| Analysts Target Price | 44.6 | 17.9% |
| ValueRay Target Price | 40.6 | 7.2% |
ARMK Fundamental Data Overview November 22, 2025
P/E Trailing = 30.3115
P/E Forward = 16.9205
P/S = 0.5252
P/B = 3.0668
P/EG = 0.6686
Beta = 1.204
Revenue TTM = 18.51b USD
EBIT TTM = 772.4m USD
EBITDA TTM = 1.25b USD
Long Term Debt = 6.25b USD (from longTermDebt, two quarters ago)
Short Term Debt = 92.3m USD (from shortTermDebt, last quarter)
Debt = 5.72b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 5.08b USD (from netDebt column, last quarter)
Enterprise Value = 14.80b USD (9.72b + Debt 5.72b - CCE 639.1m)
Interest Coverage Ratio = 2.26 (Ebit TTM 772.4m / Interest Expense TTM 341.9m)
FCF Yield = 3.07% (FCF TTM 454.5m / Enterprise Value 14.80b)
FCF Margin = 2.46% (FCF TTM 454.5m / Revenue TTM 18.51b)
Net Margin = 1.76% (Net Income TTM 326.4m / Revenue TTM 18.51b)
Gross Margin = 7.69% ((Revenue TTM 18.51b - Cost of Revenue TTM 17.08b) / Revenue TTM)
Gross Margin QoQ = 5.78% (prev 8.00%)
Tobins Q-Ratio = 1.11 (Enterprise Value 14.80b / Total Assets 13.30b)
Interest Expense / Debt = 1.57% (Interest Expense 90.0m / Debt 5.72b)
Taxrate = 19.47% (21.1m / 108.3m)
NOPAT = 622.0m (EBIT 772.4m * (1 - 19.47%))
Current Ratio = 0.99 (Total Current Assets 3.52b / Total Current Liabilities 3.55b)
Debt / Equity = 1.82 (Debt 5.72b / totalStockholderEquity, last quarter 3.15b)
Debt / EBITDA = 4.07 (Net Debt 5.08b / EBITDA 1.25b)
Debt / FCF = 11.18 (Net Debt 5.08b / FCF TTM 454.5m)
Total Stockholder Equity = 3.08b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.45% (Net Income 326.4m / Total Assets 13.30b)
RoE = 10.59% (Net Income TTM 326.4m / Total Stockholder Equity 3.08b)
RoCE = 8.27% (EBIT 772.4m / Capital Employed (Equity 3.08b + L.T.Debt 6.25b))
RoIC = 6.68% (NOPAT 622.0m / Invested Capital 9.31b)
WACC = 6.26% (E(9.72b)/V(15.44b) * Re(9.20%) + D(5.72b)/V(15.44b) * Rd(1.57%) * (1-Tc(0.19)))
Discount Rate = 9.20% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.50%
[DCF Debug] Terminal Value 76.12% ; FCFE base≈392.3m ; Y1≈444.1m ; Y5≈603.6m
Fair Price DCF = 32.28 (DCF Value 8.48b / Shares Outstanding 262.9m; 5y FCF grow 15.35% → 3.0% )
EPS Correlation: 28.49 | EPS CAGR: 12.73% | SUE: -4.0 | # QB: 0
Revenue Correlation: 68.42 | Revenue CAGR: 9.70% | SUE: -0.12 | # QB: 0
Additional Sources for ARMK Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle